Tepezza Settlement Calculator
Estimate your Tepezza hearing loss compensation
Complete or severe hearing damage
$
Advertisement
Tepezza FAQ
What is Tepezza and what does it treat?
Tepezza (teprotumumab) is the only FDA-approved treatment for Thyroid Eye Disease (TED). However, studies show 65%+ of patients experience hearing problems including permanent hearing loss and tinnitus.
When did the FDA update Tepezza warnings?
In 2023, the FDA required updated labeling to warn about hearing impairment, including permanent hearing loss. Many patients were not adequately warned before receiving treatment.
Based on official MDL 3079 court filings, FDA label warning updates (July 2023), and 2026 Audiology clinical research on IGF-1R inhibitor ototoxicity.